7 posts in this category
New 2026 genetics research explains why GLP-1s work better for some people than others, plus what to do if your response feels slower than expected.
Wegovy HD (7.2 mg) is now FDA-approved with 20.7% average weight loss. Learn about results, effects, availability, and how it compares to Zepbound.
Research shows weight regain after stopping Ozempic or Wegovy. See how fast it happens, what else reverses, and what you can do now to keep results.
Learn why weight regain can happen after GLP-1s, who is most at risk, and how to plan a long-term GLP-1 strategy safely.
Early trials of gene-silencing drugs plus GLP-1s show promising fat loss, but big questions remain. Here is what the science suggests so far.
Not all peptides are GLP-1s. Learn the difference between FDA-approved GLP-1s, pharmacy-compounded, grey market, and wellness peptides.
GLP-1 myths spread fast. Here’s the truth about Wegovy, Zepbound, side effects, “Ozempic face,” and more—backed by trusted sources.
